Robinhood Markets, Inc.’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
Robinhood Markets, Inc.'s CYTK Position: Q3 2026 in Review
Robinhood Markets, Inc. opened a new position in Cytokinetics (CYTK) in Q3 2026: 2 shares worth $146. The stake represents ﹤0.01% of the portfolio and ranks #1057 among its holdings.
470 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- Robinhood Markets, Inc. held 2 shares of Cytokinetics worth $146 as of Q3 2026.
- Cytokinetics was a new Robinhood Markets, Inc. position in Q3 2026.
- Cytokinetics made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #1057 holding.
- 470 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.